Galapagos to present progress in CF programs at NACFC 2016
MECHELEN, Belgium, Oct. 27, 2016 -- Galapagos NV will present the following plenary presentations and posters at the North American Cystic Fibrosis Conference in Orlando this week: Thursday 27 Oct. Oral session W02: CFTR 2016, 9:45 am ET Bertrand Kleizen - "The novel potentiator GLPG1837 modulates CFTR through different mode of action than ivacaftor ." Saturday 29 Oct .
from Biotech News